Gene · 4068
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Diagnosis: Hepatic Complications in Inborn Errors of Immunity. | J Clin Med | 2023 | 38068532 | PubTator, text mining | PubMed |
| Symptomatic intracranial hemorrhage mediates the association between eosinophils and 90-day outcomes after mechanical thrombectomy for acute ischemic stroke. | BMC Neurosci | 2023 | 38066457 | PubTator, text mining | PubMed |
| A Simple Nomogram for Predicting Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke. | Healthcare (Basel) | 2023 | 38063586 | PubTator, text mining | PubMed |
| Prioritizing a research agenda on built environments and physical activity: a twin panel Delphi consensus process with researchers and knowledge users. | Int J Behav Nutr Phys Act | 2023 | 38062460 | PubTator, text mining | PubMed |
| Mosaic chromosomal alterations in peripheral blood leukocytes of children in sub-Saharan Africa. | Nat Commun | 2023 | 38057307 | PubTator, text mining | PubMed |
| Prediction of asthma using a four-locus gene model including IL13, IL4, FCER1B, and ADRB2 in children of Kazak nationality. | Ital J Pediatr | 2023 | 38049812 | PubTator, text mining | PubMed |
| Adjusting perioperative methadone dose for elderly and fragile hip fracture patients (MetaHip-trial) - A statistical analysis plan for an adaptive dose-finding trial. | Contemp Clin Trials Commun | 2023 | 38047142 | PubTator, text mining | PubMed |
| Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy. | MedComm (2020) | 2023 | 38045827 | PubTator, text mining | PubMed |
| Predictive model for early death risk in pediatric hemophagocytic lymphohistiocytosis patients based on machine learning. | Heliyon | 2023 | 38045172 | PubTator, text mining | PubMed |
| The nexus between quality of customer relationship management systems and customers' satisfaction: Evidence from online customers' reviews. | Heliyon | 2023 | 38034804 | PubTator, text mining | PubMed |
| Meiotic DNA breaks drive multifaceted mutagenesis in the human germ line. | Science | 2023 | 38033082 | PubTator, text mining | PubMed |
| Master statistical analysis plan: attractive targeted sugar bait phase III trials in Kenya, Mali, and Zambia. | Trials | 2023 | 38031086 | PubTator, text mining | PubMed |
| Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application. | Front Pharmacol | 2023 | 38027031 | PubTator, text mining | PubMed |
| Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment. | Front Oncol | 2023 | 38023191 | PubTator, text mining | PubMed |
| Traditional Chinese medicine for treating aplastic anemia. | J Pharm Pharm Sci | 2023 | 38022904 | PubTator, text mining | PubMed |
| Too much of a good thing: a review of primary immune regulatory disorders. | Front Immunol | 2023 | 38022498 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis: A Rare Complication of COVID-19 in a Patient With Sickle Cell Anemia. | Cureus | 2023 | 38022077 | PubTator, text mining | PubMed |
| The pathogenesis and potential therapeutic targets in sepsis. | MedComm (2020) | 2023 | 38020710 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| New model for predicting the development of pancreatic pseudocyst secondary to acute pancreatitis. | Medicine (Baltimore) | 2023 | 38013294 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4068/papers?page=19